Medicamen Biotech Limited · Q2FY22
Result on 3 Nov 2021, first traded on 4 Nov 2021; judged on 26 Sep 2026. No read was made before it — it is recorded for the base rate. The company's page →
1 · What the read said
No read. Either the company was not on the calendar in the seven days before the result, or it was excluded that week — the trail below says which.
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the result- Delivery share
- —
- Volume
- —
- Habit held
- unknown — could not be checked
- Announced
- Thu, after the close — the reaction session is the next day
- Peers reporting
- 0 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- No read was made before this result; recorded for the base rate.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
0 morningsNo morning read was recorded for this result.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base |
|---|---|---|---|---|---|---|---|---|
| T-5 | 27 Oct | 552.10 | 574.30 | 547.00 | 552.00 | — | -8.39% | +2.14% |
| T-4 | 28 Oct | 552.50 | 552.50 | 540.20 | 550.55 | -0.26% | -8.63% | +0.16% |
| T-3 | 29 Oct | 539.55 | 570.05 | 539.55 | 563.95 | +2.43% | -6.41% | -0.88% |
| T-2 | 1 Nov | 540.00 | 574.85 | 540.00 | 561.70 | -0.40% | -6.78% | +0.56% |
| T-1 | 2 Nov | 568.05 | 628.00 | 555.20 | 592.45 | +5.47% | -1.68% | +0.34% |
| base | 3 Nov | 603.95 | 619.00 | 585.05 | 602.55 | +1.70% | +0.00% | +0.00% |
| T+1 | 4 Nov result | 685.00 | 714.85 | 630.15 | 698.70 | +15.96% | +15.96% | +0.49% |
| T+2 | 8 Nov | 697.00 | 738.00 | 654.05 | 690.60 | -1.16% | +14.61% | +1.34% |
| T+3 | 9 Nov | 680.00 | 696.35 | 655.25 | 660.70 | -4.33% | +9.65% | +1.21% |
| T+4 | 10 Nov | 674.00 | 688.70 | 649.00 | 664.35 | +0.55% | +10.26% | +1.05% |
| T+5 | 11 Nov | 655.05 | 695.00 | 640.55 | 649.85 | -2.18% | +7.85% | +0.25% |
| T+6 | 12 Nov | 675.00 | 684.90 | 610.70 | 640.30 | -1.47% | +6.27% | +1.53% |
| T+7 | 15 Nov | 675.00 | 675.00 | 621.35 | 634.45 | -0.91% | +5.29% | +1.57% |
| T+8 | 16 Nov | 659.90 | 659.90 | 606.95 | 650.15 | +2.47% | +7.90% | +0.95% |
| T+9 | 17 Nov | 650.05 | 668.95 | 630.95 | 651.55 | +0.22% | +8.13% | +0.39% |
| T+10 | 18 Nov | 651.60 | 659.80 | 612.40 | 622.50 | -4.46% | +3.31% | -0.36% |
| T+11 | 22 Nov | 664.00 | 664.00 | 541.60 | 582.40 | -6.44% | -3.34% | -2.31% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.